GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Change In Other Working Capital

BCAL Diagnostics (ASX:BDX) Change In Other Working Capital : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Change In Other Working Capital?

BCAL Diagnostics's Change In Other Working Capital for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means BCAL Diagnostics's Other Working Capital stayed the same from Jun. 2023 to Dec. 2023 .

BCAL Diagnostics's Change In Other Working Capital for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means BCAL Diagnostics's Other Working Capital stayed the same from Jun. 2022 to Jun. 2023 .

BCAL Diagnostics Change In Other Working Capital Historical Data

The historical data trend for BCAL Diagnostics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Change In Other Working Capital Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Change In Other Working Capital
- -

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Other Working Capital Get a 7-Day Free Trial - - - - -

BCAL Diagnostics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Change In Other Working Capital
Comparable Companies
ASX:GTG ASX:CTE ASX:LDX ASX:IBX ASX:RHY ASX:IIQ ASX:GSS ASX:MAP TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX
Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
Website
https://www.bcaldiagnostics.com
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.